Abstract

The present invention relates to novel solid-state forms of Muvalaplin, including crystalline polymorphs, amorphous forms, and co-crystals, processes for their preparation, and their use in pharmaceutical compositions.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS